Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 6, 2010 - Issue 1
Submit an article Journal homepage
349
Views
99
CrossRef citations to date
0
Altmetric
Drug Evaluations

Efavirenz in the therapy of HIV infection

Natella Y Rakhmanina The George Washington University, School of Medicine and Health Sciences, Department of Pediatrics, and Director, Special Immunology Program, Children's National Medical Center, Division of Infectious Disease, 111 Michigan Avenue, NW, Washington, DC 20010, USA +1 202 476 2083; +1 202 476 3850; [email protected]; The George Washington University, School of Medicine and Health Sciences, Children's National Medical Center, Division of Pediatric Clinical Pharmacology and Department of Pediatrics, 111 Michigan Avenue, NW, Washington, DC 20010, USA
, MD FAAP AAHIVS (Associate Professor of Pediatrics) &
John N van den Anker The George Washington University, School of Medicine and Health Sciences, Children's National Medical Center, Division of Pediatric Clinical Pharmacology and Department of Pediatrics, 111 Michigan Avenue, NW, Washington, DC 20010, USA; The George Washington University, School of Medicine and Health Sciences, Children's National Medical Center, Department of Pharmacology and Physiology, 111 Michigan Avenue, NW, Washington, DC 20010, USA
, MD PhD (Professor of Pediatrics, Pharmacology & Physiology)
Pages 95-103 | Published online: 13 Dec 2009

Citations (99)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Jaya P. Ambhore, Suraj R. Chaudhari, Rameshwar S. Cheke & Prashant S. Kharkar. (2022) A Concise Analytical Profile of Efavirenz: Analytical Methodologies. Critical Reviews in Analytical Chemistry 52:7, pages 1583-1592.
Read now
Pansachee Damronglerd, Chonlaphat Sukasem, Wilawan Thipmontree, Apichaya Puangpetch & Sasisopin Kiertiburanakul. (2015) A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study. Pharmacogenomics and Personalized Medicine 8, pages 155-162.
Read now
Leonardo Calza, Ilaria Danese, Vincenzo Colangeli, Roberto Manfredi, Eleonora Magistrelli, Gabriella Verucchi, Matteo Conti, Roberto Motta & Pierluigi Viale. (2015) Plasma concentrations of efavirenz, darunavir/ritonavir and raltegravir in HIV-HCV-coinfected patients without liver cirrhosis in comparison with HIV-monoinfected patients. Infectious Diseases 47:9, pages 625-636.
Read now
Pablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, Pablo Labarga & Vincent Soriano. (2014) Pharmacogenetics of antiretroviral therapy. Expert Opinion on Drug Metabolism & Toxicology 10:8, pages 1119-1130.
Read now
W. Spreen, S. Min, S. L. Ford, S. Chen, Y. Lou, M. Bomar, M. St Clair, S. Piscitelli & T. Fujiwara. (2013) Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor. HIV Clinical Trials 14:5, pages 192-203.
Read now
JohnA. Davis. (2013) HIV and the LGBT Community: A Medical Update. Journal of Gay & Lesbian Mental Health 17:1, pages 64-79.
Read now
Rebecca Pavlos & Elizabeth J Phillips. (2012) Individualization of antiretroviral therapy. Pharmacogenomics and Personalized Medicine 5, pages 1-17.
Read now
Mona Arab-Alameddine, Laurent Arhtur Décosterd, Thierry Buclin, Amalio Telenti & Chantal Csajka. (2011) Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics. Expert Opinion on Drug Metabolism & Toxicology 7:5, pages 609-622.
Read now

Articles from other publishers (91)

Xian Pan & Karen Rowland Yeo. (2023) Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding Infants. Clinical Pharmacology & Therapeutics 114:1, pages 182-191.
Crossref
Nduduzo Ngwenya & Precious Mahlambi. (2023) Methods optimization and application: Solid phase extraction, ultrasonic extraction and Soxhlet extraction for the determination of antiretroviral drugs in river water, wastewater, sludge, soil and sediment. Journal of Pharmaceutical and Biomedical Analysis 230, pages 115358.
Crossref
Relja SurucicV.V., Ivana JevticI.I., Tatjana StanojkovicP.P. & Jelena Popovic-DjordjevicB.B.. (2023) Antidiabetic potential of simple carbamate derivatives: Comparative experimental and computational study. Journal of the Serbian Chemical Society 88:11, pages 1089-1102.
Crossref
Phephile Ngwenya & Ndeke Musee. (2023) Modelling ecological risks of antiretroviral drugs in the environment. Environmental Chemistry and Ecotoxicology 5, pages 145-154.
Crossref
Bárbara Costa & Nuno Vale. (2022) Efavirenz: History, Development and Future. Biomolecules 13:1, pages 88.
Crossref
Soumik De, Aritra Kumar Dan, Raghaba Sahu & Debadutta Das. (2022) Asymmetric Synthesis of Halocyclized Products by Using Various Catalysts: A State‐of‐the‐Art Review. European Journal of Organic Chemistry 2022:32.
Crossref
Angélica Saraí Jiménez-Osorio, Sinaí Jaen-Vega, Eduardo Fernández-Martínez, María Araceli Ortíz-Rodríguez, María Fernanda Martínez-Salazar, Reyna Cristina Jiménez-Sánchez, Olga Rocío Flores-Chávez, Esther Ramírez-Moreno, José Arias-Rico, Felipe Arteaga-García & Diego Estrada-Luna. (2022) Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals. International Journal of Molecular Sciences 23:10, pages 5592.
Crossref
Marise Nel, Halima Samsodien & Marique Elizabeth Aucamp. (2022) Using natural excipients to enhance the solubility of the poorly water-soluble antiretroviral, efavirenz. Journal of Drug Delivery Science and Technology 71, pages 103332.
Crossref
Yongquan Ning, Mengtian Huo, Lizuo Wu & Xihe Bi. (2022) Silver-catalyzed cyclopropanation of alkenes with alkynyl N -nosylhydrazones leading to alkynyl cyclopropanes . Chemical Communications 58:21, pages 3485-3488.
Crossref
Vishal C Gurumukhi & Sanjaykumar B Bari. (2022) Quantification and Validation of Stability-Indicating RP-HPLC Method for Efavirenz in Bulk and Tablet Dosage Form using Quality by Design (QbD): A Shifting Paradigm. Journal of Chromatographic Science 60:2, pages 143-156.
Crossref
Jing Ke, Wan-Chen Cindy Lee, Xiaoxu Wang, Yong Wang, Xin Wen & X. Peter Zhang. (2022) Metalloradical Activation of In Situ-Generated α-Alkynyldiazomethanes for Asymmetric Radical Cyclopropanation of Alkenes. Journal of the American Chemical Society 144:5, pages 2368-2378.
Crossref
Suranie Horn, Tash Vogt, Elisca Gerber, Bianca Vogt, Hindrik Bouwman & Rialet Pieters. (2022) HIV-antiretrovirals in river water from Gauteng, South Africa: Mixed messages of wastewater inflows as source. Science of The Total Environment 806, pages 150346.
Crossref
Ramreddy Godela, Vijayalaxmi Kammari, Sowjanya Gummadi & Durgaprasad Beda. (2021) Concurrent estimation of lamivudine, tenofovir disoproxil fumarate, and efavirenz in blended mixture and triple combination tablet formulation by a new stability indicating RP-HPLC method. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Tahir Ali, Samia Hannaoui, Satish Nemani, Waqas Tahir, Irina Zemlyankina, Pearl Cherry, Su Yeon Shim, Valerie Sim, Hermann M. Schaetzl & Sabine Gilch. (2021) Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice. Acta Neuropathologica Communications 9:1.
Crossref
Xian-min Meng, Zi-ran Li, Xin-yin Zheng, Yi-xi Liu, Wan-jie Niu, Xiao-yan Qiu & Hong-zhou Lu. (2021) Effect of albumin and CYP2B6 polymorphisms on exposure of efavirenz: A population pharmacokinetic analysis in Chinese HIV-infected adults. European Journal of Pharmaceutical Sciences 167, pages 105986.
Crossref
Masixole Yvonne Lugongolo, Sello Lebohang Manoto, Saturnin Ombinda-Lemboumba, Malik Maaza & Patience Mthunzi-Kufa. (2021) The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells. Biomedical Journal 44:6, pages S37-S47.
Crossref
Spencer H. Durham & Elias B. Chahine. (2021) Cabotegravir-Rilpivirine: The First Complete Long-Acting Injectable Regimen for the Treatment of HIV-1 Infection. Annals of Pharmacotherapy 55:11, pages 1397-1409.
Crossref
Karen Reddy, Nirmal Renuka, Sheena Kumari & Faizal Bux. (2021) Algae-mediated processes for the treatment of antiretroviral drugs in wastewater: Prospects and challenges. Chemosphere 280, pages 130674.
Crossref
Mauro Mato, Marc Montesinos-Magraner, Arnau R. Sugranyes & Antonio M. Echavarren. (2021) Rh(II)-Catalyzed Alkynylcyclopropanation of Alkenes by Decarbenation of Alkynylcycloheptatrienes. Journal of the American Chemical Society 143:28, pages 10760-10769.
Crossref
Immaculate M. Langmia, Katja S. Just, Sabrina Yamoune, Jürgen Brockmöller, Collen Masimirembwa & Julia C. Stingl. (2021) CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized Therapy. Frontiers in Genetics 12.
Crossref
Ali Irfan, Sami Ullah, Ayesha Anum, Nazish Jabeen, Ameer Fawad Zahoor, Hafza Kanwal, Katarzyna Kotwica-Mojzych & Mariusz Mojzych. (2021) Synthetic Transformations and Medicinal Significance of 1,2,3-Thiadiazoles Derivatives: An Update. Applied Sciences 11:12, pages 5742.
Crossref
Patrick Rollin, Liane K. Soares, Angelita M. Barcellos, Daniela R. Araujo, Eder J. Lenardão, Raquel G. Jacob & Gelson Perin. (2021) Five-Membered Cyclic Carbonates: Versatility for Applications in Organic Synthesis, Pharmaceutical, and Materials Sciences. Applied Sciences 11:11, pages 5024.
Crossref
Gerald MboowaIvan SserwaddaDickson Aruhomukama. (2021) Genomics and bioinformatics capacity in Africa: no continent is left behind. Genome 64:5, pages 503-513.
Crossref
Joseph Ali, Jong Bong Lee, Sally Gittings, Alessandro Iachelini, Joanne Bennett, Anne Cram, Martin Garnett, Clive J. Roberts & Pavel Gershkovich. (2021) Development and optimisation of simulated salivary fluid for biorelevant oral cavity dissolution. European Journal of Pharmaceutics and Biopharmaceutics 160, pages 125-133.
Crossref
Min-Song Wu, Zhi-Yong Han & Liu-Zhu Gong. (2021) Asymmetric α-Pentadienylation of Aldehydes with Cyclopropylacetylenes. Organic Letters 23:3, pages 636-641.
Crossref
Lili Dai, Bin Su, An Liu, Hongwei Zhang, Hao Wu, Tong Zhang, Ying Shao, Jianwei Li, Jiangzhu Ye, Shaoli Bai, Xiaoling Guo & Lijun Sun. (2020) Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy. BMC Infectious Diseases 20:1.
Crossref
Irna Sufiawati, Ani Melani Maskoen & Eky Setiawan Soeria Soemantri. (2020) Genetic variation of IRF 6 and TGFA genes in an HIV‐exposed newborn with non‐syndromic cleft lip palate . Oral Diseases 26:S1, pages 165-168.
Crossref
Herana Kamal Seneviratne, Allyson N. Hamlin, Carley J. S. Heck & Namandjé N. Bumpus. (2020) Spatial Distribution Profiles of Emtricitabine, Tenofovir, Efavirenz, and Rilpivirine in Murine Tissues Following In Vivo Dosing Correlate with Their Safety Profiles in Humans . ACS Pharmacology & Translational Science 3:4, pages 655-665.
Crossref
Manoranjenni Chetty, Michael P. Danckwerts & Andrea Julsing. (2020) Prediction of the exposure to a 400-mg daily dose of efavirenz in pregnancy: is this dose adequate in extensive metabolisers of CYP2B6?. European Journal of Clinical Pharmacology 76:8, pages 1143-1150.
Crossref
Mei Tan, Megan Bowers, Phil Thuma & Elena L. Grigorenko. (2020) The Pharmacogenetics of Efavirenz Metabolism in Children: The Potential Genetic and Medical Contributions to Child Development in the Context of Long‐Term ARV Treatment. New Directions for Child and Adolescent Development 2020:171, pages 107-133.
Crossref
Panneerselvam Kalaivani, Jayaraman Arikrishnan & Mannuthusamy Gopalakrishnan. (2020) Design, Synthesis, Molecular Docking and Antimicrobial Evaluation of Some Tosyl Carbamate Derivatives. Asian Journal of Chemistry 32:4, pages 783-788.
Crossref
Pan-Fen Wang, Alicia Neiner & Evan D. Kharasch. (2019) Efavirenz Metabolism: Influence of Polymorphic CYP2B6 Variants and Stereochemistry. Drug Metabolism and Disposition 47:10, pages 1195-1205.
Crossref
Dhanashree H. Surve & Anil B. Jindal. (2019) Development and validation of reverse-phase high-performance liquid chromatographic (RP-HPLC) method for quantification of Efavirenz in Efavirenz-Enfuvirtide co-loaded polymer-lipid hybrid nanoparticles. Journal of Pharmaceutical and Biomedical Analysis 175, pages 112765.
Crossref
Xue Zhao, Shihai Yang, Saeideh Ebrahimiasl, Sattar Arshadi & Akram Hosseinian. (2019) Synthesis of six-membered cyclic carbamates employing CO2 as building block: A review. Journal of CO2 Utilization 33, pages 37-45.
Crossref
Simon Marie Peko, Nerly Shirère Gampio Gueye, Christevy Vouvoungui, Félix Koukouikila-Koussounda, Simon Charles Kobawila, David Nderu, Thirumalaisamy P. Velavan & Francine Ntoumi. (2019) Cytochrome P450 CYP2B6*6 distribution among Congolese individuals with HIV, Tuberculosis and Malaria infection. International Journal of Infectious Diseases 82, pages 111-116.
Crossref
Sulav Duwal, Daniel Seeler, Laura Dickinson, Saye Khoo & Max von Kleist. (2019) The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis. Frontiers in Pharmacology 10.
Crossref
Rajeev K. Mehlotra. (2018) Human Genetic Variation and HIV/AIDS in Papua New Guinea: Time to Connect the Dots. Current HIV/AIDS Reports 15:6, pages 431-440.
Crossref
Thien Phuc Le, Kazuyuki Higashita, Shinji Tanaka, Masahiro Yoshimura & Masato Kitamura. (2018) Revisiting the Cu II -Catalyzed Asymmetric Friedel–Crafts Reaction of Indole with Trifluoropyruvate . Organic Letters 20:22, pages 7149-7153.
Crossref
Jullye Campos Mendes, Palmira de Fátima Bonolo, Maria das Graças Braga Ceccato, Juliana de Oliveira Costa, Adriano Max Moreira Reis, Henrique dos Santos & Micheline Rosa Silveira. (2018) Adverse reactions associated with first-line regimens in patient initiating antiretroviral therapy. European Journal of Clinical Pharmacology 74:8, pages 1077-1088.
Crossref
Hind Hassani Idrissi, Nada El Khorb, Abdelhafid Akoudad, Rachida Habbal & Sellama Nadifi. (2018) Association of CYP2B6 ( G15631T ) polymorphism with Clopidogrel resistance and genetic predisposition to Acute Coronary Syndromes (ACSs) in Morocco. Gene Reports 11, pages 244-249.
Crossref
Ovokeroye A. Abafe, Jana Späth, Jerker Fick, Stina Jansson, Chris Buckley, Annegret Stark, Bjoern Pietruschka & Bice S. Martincigh. (2018) LC-MS/MS determination of antiretroviral drugs in influents and effluents from wastewater treatment plants in KwaZulu-Natal, South Africa. Chemosphere 200, pages 660-670.
Crossref
Alice King, Andreas Doepner, David Turton, Daniela M. Ciobota, Chiara Da Pieve, Anne-Christine Wong Te Fong, Gabriela Kramer-Marek, Yuen-Li Chung & Graham Smith. (2018) Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18 F-trifluoromethylation procedure . Organic & Biomolecular Chemistry 16:16, pages 2986-2996.
Crossref
MM Gutierrez, G Pillai, S Felix, F Romero, KO Onyango, S Owusu-Agyei, KP Asante, KI Barnes, P Sinxadi, E Allen, S Abdulla, C Masimirembwa, M Munyoro, G Yimer, T Gebre-Mariam, J Spector & B Ogutu. (2017) Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa. Clinical Pharmacology & Therapeutics 102:5, pages 786-795.
Crossref
P Kumar, YS Lakshmi & AK Kondapi. (2016) An oral formulation of efavirenz‐loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile. HIV Medicine 18:7, pages 452-462.
Crossref
Aroldo Vieira de Moraes Filho, Cláudia de Jesus Silva Carvalho, Cícero Jorge Verçosa, Macks Wendhell Gonçalves, Cláudia Rohde, Daniela de Melo e Silva, Kênya Silva Cunha & Lee Chen-Chen. (2017) In vivo genotoxicity evaluation of efavirenz (EFV) and tenofovir disoproxil fumarate (TDF) alone and in their clinical combinations in Drosophila melanogaster. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 820, pages 31-38.
Crossref
TALISE E. MÜLLER, JOEL H. ELLWANGER, RAFAEL T. MICHITA, MARIA CRISTINA C. MATTE & JANE D.P. RENNER. (2017) CYP2B6 516 G>T polymorphism and side effects of the central nervous system in HIV-positive individuals under Efavirenz treatment: Study of a sample from southern Brazil. Anais da Academia Brasileira de Ciências 89:1 suppl, pages 497-504.
Crossref
Lucie Zelena, Josef Reznicek, Martina Ceckova & Hana Sklenarova. (2017) Universal efavirenz determination in transport study, rat placenta perfusion and placenta lysate by HPLC-UV. Journal of Pharmaceutical and Biomedical Analysis 137, pages 70-77.
Crossref
Elyse J. Singer & Natasha M. Nemanim. 2017. Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS 375 403 .
Philip M. Cox & Namandjé N. Bumpus. (2016) Single Heteroatom Substitutions in the Efavirenz Oxazinone Ring Impact Metabolism by CYP2B6. ChemMedChem 11:23, pages 2630-2637.
Crossref
Judy T. Orikiiriza. (2016) Rollout of efavirenz-based regimens in option B+ in the prevention of mother-to-child transmission programs. AIDS 30:15, pages N29-N31.
Crossref
William D. Hedrich, Hazem E. Hassan & Hongbing Wang. (2016) Insights into CYP2B6-mediated drug–drug interactions. Acta Pharmaceutica Sinica B 6:5, pages 413-425.
Crossref
Ying-Yuan Lu, Xiao-Wei Wang, Xin Wang, Wen-Bing Dai, Qiang Zhang, Pu Li, Ya-Qing Lou, Chuang Lu, Jun-Yi Liu & Guo-Liang Zhang. (2016) Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats. Archives of Pharmacal Research 39:7, pages 970-977.
Crossref
Lisa Van de Wijer, Arnt F A Schellekens, David M Burger, Judith R Homberg, Quirijn de Mast & Andre J A M van der Ven. (2016) Rethinking the risk–benefit ratio of efavirenz in HIV-infected children. The Lancet Infectious Diseases 16:5, pages e76-e81.
Crossref
Virginia Melis, Iris Usach, Patricia Gandía & José-Esteban Peris. (2016) Inhibition of Efavirenz Metabolism by Sertraline and Nortriptyline and Their Effect on Efavirenz Plasma Concentrations. Antimicrobial Agents and Chemotherapy 60:2, pages 1022-1028.
Crossref
Gianluca Russo, Giacomo Maria Paganotti, Sandra Soeria-Atmadja, Miriam Haverkamp, Doreen Ramogola-Masire, Vincenzo Vullo & Lars Lennart Gustafsson. (2016) Pharmacogenetics of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in resource-limited settings: Influence on antiretroviral therapy response and concomitant anti-tubercular, antimalarial and contraceptive treatments. Infection, Genetics and Evolution 37, pages 192-207.
Crossref
Mônica M. Bastos, Carolina C.P. Costa, Talitha C. Bezerra, Fernando de C. da Silva & Núbia Boechat. (2016) Efavirenz a nonnucleoside reverse transcriptase inhibitor of first-generation: Approaches based on its medicinal chemistry. European Journal of Medicinal Chemistry 108, pages 455-465.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 687 736 .
Marlene Weiß, Bernd Kost, Ingrid Renner-Müller, Eckhard Wolf, Ioannis Mylonas & Ansgar Brüning. (2015) Efavirenz Causes Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Endothelial Cells. Cardiovascular Toxicology 16:1, pages 90-99.
Crossref
Marc Montesinos-Magraner, Carlos Vila, Gonzalo Blay, Isabel Fernández, M. Carmen Muñoz & José R. Pedro. (2015) Organocatalytic Enantioselective Friedel-Crafts Alkylation of 1-Naphthol Derivatives and Activated Phenols with Ethyl Trifluoropyruvate. Advanced Synthesis & Catalysis 357:14-15, pages 3047-3051.
Crossref
Wusheng GuoJoan Gónzalez‐FabraNuno A. G. BandeiraCarles BoArjan W. Kleij. (2015) A Metal‐Free Synthesis of N‐Aryl Carbamates under Ambient Conditions. Angewandte Chemie International Edition 54:40, pages 11686-11690.
Crossref
Wusheng Guo, Joan Gónzalez‐Fabra, Nuno A. G. Bandeira, Carles Bo & Arjan W. Kleij. (2015) A Metal‐Free Synthesis of N‐Aryl Carbamates under Ambient Conditions. Angewandte Chemie 127:40, pages 11852-11856.
Crossref
Paulo Roberto Xavier Tomaz, Juliana Rocha Santos, Jaqueline Scholz Issa, Tânia Ogawa Abe, Patrícia Viviane Gaya, José Eduardo Krieger, Alexandre Costa Pereira & Paulo Caleb Júnior Lima Santos. (2015) CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy. European Journal of Clinical Pharmacology 71:9, pages 1067-1073.
Crossref
Adeniyi Olagunju, Oluseye Bolaji, Alieu Amara, Catriona Waitt, Laura Else, Ebunoluwa Adejuyigbe, Marco Siccardi, David Back, Saye Khoo & Andrew Owen. (2015) Breast Milk Pharmacokinetics of Efavirenz and Breastfed Infants' Exposure in Genetically Defined Subgroups of Mother-Infant Pairs: An Observational Study. Clinical Infectious Diseases 61:3, pages 453-463.
Crossref
N. B. Bhatt, C. Barau, A. Amin, E. Baudin, B. Meggi, C. Silva, V. Furlan, B. Grinsztejn, A. Barrail-Tran, M. Bonnet & A. M. Taburet. (2014) Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment. Antimicrobial Agents and Chemotherapy 58:6, pages 3182-3190.
Crossref
Panjasaram Naidoo, Vasudevan V. Chetty & Manoranjenni Chetty. (2014) Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz. European Journal of Clinical Pharmacology 70:4, pages 379-389.
Crossref
Julie Bertrand, Céline Verstuyft, Monidarin Chou, Laurence Borand, Phalla Chea, Kuy Huong Nay, François-Xavier Blanc, France Mentré, Anne-Marie Taburet, Thim Sok, Anne E. Goldfeld, François-Xavier Blanc, Didier Laureillard, Olivier Marcy, Marcelo Fernandez, Sarin Chan, Eric Nerrienet, Sirenda Vong, Yoann Madec, Claire Rekacewicz, Manil Saman, Chanthy Leng, Sao Sarady Ay, Phearavin Pheng, Lay Heng Chan, Sophea Suom, Nimul Roat Men, Kerya Phon, Sopheap Kun, Sokeo Chea, Pichda Toeung, Yong Yoeun, Keo Kunthea Dy, Pheakun Kry, Keolinelyanneth Meardey, Bertrand Guillard, Chanthan Srey, Chantary Keo, Sopheak Ngin, Borann Sar, Janin Nouhin, Sreymom Ken, Kimlay Chea, Kunthea Kong, Sophy Tun, Leakhena Say, Kim Eng Sok & Hok Kean Lim. (2014) Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms: ANRS 12154 Study in Cambodia. The Journal of Infectious Diseases 209:3, pages 399-408.
Crossref
Long Ren & Ning Jiao. (2014) PdCl2 catalyzed efficient assembly of organic azides, CO, and alcohols under mild conditions: a direct approach to synthesize carbamates. Chemical Communications 50:28, pages 3706.
Crossref
Mette S van Ramshorst, Magdeline Kekana, Helen E Struthers, James A McIntyre & Remco PH Peters. (2013) Efavirenz-induced gynecomastia in a prepubertal girl with human immunodeficiency virus infection: a case report. BMC Pediatrics 13:1.
Crossref
Marco SiccardiRajith Kumar Reddy Rajoli, Paul Curley, Adeniyi Olagunju, Darren Moss & Andrew Owen. (2013) Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective. Future Virology 8:9, pages 871-890.
Crossref
Marelize Swart, Michelle Skelton, Yuan Ren, Peter Smith, Simbabrashe Takuva & Collet Dandara. (2013) High predictive value of CYP2B6 SNPs for steady-state plasma efavirenz levels in South African HIV/AIDS patients. Pharmacogenetics and Genomics 23:8, pages 415-427.
Crossref
Ulrich M. Zanger & Matthias Schwab. (2013) Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics 138:1, pages 103-141.
Crossref
Iris Usach, Virginia Melis & José-Esteban Peris. (2013) Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability. Journal of the International AIDS Society 16:1, pages 18567.
Crossref
Chris Kenyon, Sipho Mfolozi, Roland Croxford, Robert Colebunders & Karen Cohen. (2012) Severe efavirenz‐induced vacuolar axonopathy complicated by fatal aspiration pneumonia. British Journal of Clinical Pharmacology 74:6, pages 1070-1072.
Crossref
Natella Rakhmanina & B. Ryan Phelps. (2012) Pharmacotherapy of Pediatric HIV Infection. Pediatric Clinics of North America 59:5, pages 1093-1115.
Crossref
Ellen M. McDonagh, Catherine Wassenaar, Sean P. David, Rachel F. Tyndale, Russ B. Altman, Michelle Whirl-Carrillo & Teri E. Klein. (2012) PharmGKB summary. Pharmacogenetics and Genomics 22:9, pages 695-708.
Crossref
Guido Antonelli & Ombretta Turriziani. (2012) Antiviral therapy: old and current issues. International Journal of Antimicrobial Agents 40:2, pages 95-102.
Crossref
Jing Li, Vincent Menard, Rebekah L Benish, Richard J Jurevic, Chantal Guillemette, Mark Stoneking, Peter A Zimmerman & Rajeev K Mehlotra. (2012) Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7 : implications for HIV/AIDS treatment . Pharmacogenomics 13:5, pages 555-570.
Crossref
Sandra G. Heil, Marchina E. van der Ende, Paul W. Schenk, Ilse van der Heiden, Jan Lindemans, David Burger & Ron H. N. van Schaik. (2012) Associations Between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 Alleles in Relation to Efavirenz and Nevirapine Pharmacokinetics in HIV-Infected Individuals. Therapeutic Drug Monitoring 34:2, pages 153-159.
Crossref
E D Kharasch, D Whittington, D Ensign, C Hoffer, P S Bedynek, S Campbell, K Stubbert, A Crafford, A London & T Kim. (2012) Mechanism of Efavirenz Influence on Methadone Pharmacokinetics and Pharmacodynamics. Clinical Pharmacology & Therapeutics 91:4, pages 673-684.
Crossref
Jose R Castillo-MancillaThomas B Campbell. (2012) Comparative effectiveness of efavirenz-based antiretroviral regimens in resource-limited settings. Journal of Comparative Effectiveness Research 1:2, pages 157-170.
Crossref
S Oswald, H E Meyer zu Schwabedissen, A Nassif, C Modess, Z Desta, E T Ogburn, J Mostertz, M Keiser, J Jia, A Hubeny, A Ulrich, D Runge, M Marinova, D Lütjohann, H K Kroemer & W Siegmund. (2012) Impact of Efavirenz on Intestinal Metabolism and Transport: Insights From an Interaction Study With Ezetimibe in Healthy Volunteers. Clinical Pharmacology & Therapeutics 91:3, pages 506-513.
Crossref
Hye Young Ji, Hyeri Lee, Sae Rom Lim, Jeong Han Kim & Hye Suk Lee. (2012) Effect of Efavirenz on UDP-Glucuronosyltransferase 1A1, 1A4, 1A6, and 1A9 Activities in Human Liver Microsomes. Molecules 17:1, pages 851-860.
Crossref
Sofia A. Pereira, Riccardo Wanke, M. Matilde Marques, Emília C. Monteiro & Alexandra M.M. Antunes. 2012. Advances in Molecular Toxicology Volume 6. Advances in Molecular Toxicology Volume 6 1 39 .
Juan Gonzalo Restrepo, Carmen Martínez, Augusto García-Agúndez, Elmer Gaviria, José Julio Laguna, Elena García-Martín & José A.G. Agúndez. (2011) Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population. Pharmacogenetics and Genomics 21:12, pages 773-778.
Crossref
Elna van der Ryst, Michael J Palmer & Cloete van Vuuren. 2011. Neglected Diseases and Drug Discovery. Neglected Diseases and Drug Discovery 322 365 .
Roxana N. Peroni, Stefania S. Di Gennaro, Christian Hocht, Diego A. Chiappetta, Modesto C. Rubio, Alejandro Sosnik & Guillermo F. Bramuglia. (2011) Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat. Biochemical Pharmacology 82:9, pages 1227-1233.
Crossref
Rui-Juan Niu, Qing-Chuan Zheng, Ji-Long Zhang & Hong-Xing Zhang. (2011) Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. Journal of Molecular Modeling 17:11, pages 2839-2846.
Crossref
B. Ryan Phelps & Natella Rakhmanina. (2011) Antiretroviral Drugs in Pediatric HIV-Infected Patients. Pediatric Drugs 13:3, pages 175-192.
Crossref
Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, Saye Khoo, Concepta Merry & Jean-Pierre Van geertruyden. (2011) Artemether-Lumefantrine Combination Therapy for Treatment of Uncomplicated Malaria: The Potential for Complex Interactions with Antiretroviral Drugs in HIV-Infected Individuals. Malaria Research and Treatment 2011, pages 1-5.
Crossref
Christian Wolf & Peng Zhang. (2011) Asymmetric Friedel–Crafts Reaction of Indoles with Ethyl Trifluoropyruvate Using a Copper(I)‐Bisoxazolidine Catalyst. Advanced Synthesis & Catalysis 353:5, pages 760-766.
Crossref
Salvador Cabrera Figueroa, María Fernández de Gatta, Lorena Hernández García, Alfonso Domínguez-Gil Hurlé, Carmen Bustos Bernal, Rosa Sepúlveda Correa & María José García Sánchez. (2010) The Convergence of Therapeutic Drug Monitoring and Pharmacogenetic Testing to Optimize Efavirenz Therapy. Therapeutic Drug Monitoring 32:5, pages 579-585.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.